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The phenomenon of immune deviation (1), also termed split tolerance (2)  or 
contrasensitization  (3),  seems to be of crucial importance in  trying to under- 
stand  the relations between the two phenomena of immunological facilitation 
(enhancement) and immunological tolerance (4). Its mechanism is possibly due 
to  a  selective immunodepressive action  of various imrnunoglobulin  classes of 
antibodies  on  active  antibody  production  of  various  classes.  The  preceding 
article has indeed shown the differential effect of passive IgG1 and IgG2 anti- 
hapten  antibodies  on  the  antibody production  of these  two classes,  the  main 
finding being the delayed enhancing effect of passive IgG1 on their own produc- 
tion. 1 
On the other hand, hapten-carrier relationships have been reported in several 
immunological systems and,  more recently, interpreted within the frame of T 
cell-B cell cooperation  (reviewed in 5). Immunization of the guinea pig with a 
highly hapten-substituted carrier protein leads to antibody production against 
the hapten and delayed hypersensitivity to the carrier moiety (6). It has there- 
fore been thought of interest to look for the possible effects of passive IgG1 and 
IgG2 anticarrier antibodies on the active IgG1 and IgG2 antihapten response. 
The present experiments carried along with the precedingly reported ones  1 deal 
mainly with these effects. 
As it will be seen,  the observed results are best explained by postulating a 
regulatory function  of the  Fc portion of the  IgG1  anticarrier antibody,  com- 
bined with the antigen, on the T  cell. 
Materials and Methods 
Animals.--Anfibody  donors and recipients were adult  Hartley guinea pigs, of the same 
origin and kept together with those used in experiments reported elsewhere.  1 
* Partially supported by DGRST (Grant 71-7-2942). 
:~ Team associated with the Centre National de la Recherche Scientifique (E.R.A. 149). 
1  Vuagnat, P., T. Neveu, and  G. A. Voisin. 1973. Immunodeviation by passive antibody, 
an expression of selective immunodepression. I. Action of guinea pig IgG1 and IgG2 anti- 
hapten antibodies. Eur. Y. Immunol.  In press. 
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Antigens.--Bovine gamma globulin (BGG) 2 and bovine serum albumin (BSA) were dinitro- 
phenylated by the method of Eisen (7). The conjugated proteins were purified by acid pre- 
cipitation  or  by  filtration  on  Sephadex  G-25. The  same preparation of DNP~I-BGG and 
DNP 6-BSA was used throughout the experiments. Subscripts refer to the average number of 
dinitrophenyl (DNP) groups per protein molecule,  calculated from the absorbance at 360 nm 
and the dry weight. 
Human gamma globulin  (HGG)  was separated from Cohn fraction II by DEAE-cellulose 
chromatography, using a 0.01 M TIis-HC1 buffer, pH 8.0. 
Pa,~sive Amibodies.--Guinea pigs were immunized as described by Binaghi (8) and bled on 
day 30. The sera were pooled and decomplemented by heating 30 rain at 56°C, and aliquots 
were adsorbed on polymerized HGG (9). Anti-HGG antibodies were eluted with 0.1 M glycine- 
HC1 buffer, pH 2.8, with a yield of 59%. Pooled eluates were chromatographed on a DEAE- 
cellulose column equilibrated with 0.004 M phosphate buffer, pH 7.40. After collection of the 
IgG2 in the effluent,  the IgG1 were eluted with a  linear NaC1 gradient. The fraction eluted 
between 0.04 and 0.1 M NaC1 was selected. 
After concentration to 9 mg/ml, both IgG1  and IgG2 fractions had a titer of 1 : 10,000 by 
passive hemagglutination. The IgG2 fraction had a titer of 1 : 16,000 by passive hemolysis, and 
of  1:5  by passive cutaneous anaphylaxis  (PCA),  although no IgG1  could be antigenically 
detected by the Ouchterlony technique. The IgG1 fraction has a PCA titer of 1:8,000  and a 
hemolytic titer of 0, even though some IgG2 could be antigenically detected. 
The relative avidity of the IgG1  and IgG2 antibodies was found to be similar,  using the 
method described by Cerottini et al.  (10). IgG1  and IgG2 antibodies were used at the concen- 
tration of 2 #g/ml of 0.15 M  borate buffer,  pH 8.2,  containing a  1:15  dilution of a  hyper- 
immune guinea pig antlovalbumin serum as carrier.  [125I]HGG (22  nCi/~g)  was  obtained 
according to the method of McConahey and Dixon (11). After overnight incubation at 36°C 
in a shaking water bath and sampling, a 300-fold  excess of cold HGG was added. Aliquots 
were sampled at given intervals thereafter, starting on the 10th  rain.  IgGl- or IgG2-bound 
radioactivity was  determined  by  precipitation with  a  preheated  anti-IgG1  or  anti-IgG2 
monospecific  rabbit serum. All determinations were done in duplicate, along with the neces- 
sary controls. 
Finally, sheep red blood cells were coated with dinitrophenylated bovine gamma globulin 
(DNP51-BGG)  by the chromium chloride method (12). A  1.5% concentration of  CrC18 was 
found to be adequate. With this antigen, anti-HGG IgG2 were three twofold  dilutions  less 
effective in the passive hemagglutination test than purified anti-BGG IgG2 used at the same 
concentration. 
Immunization of Experimental Animals.--This was done under the same conditions and at 
the same time as the immunization of the animals used in previous experiments.  I Allocation of 
animals  into  groups  homogeneous for sex  and  weight,  and  allocation  of  treatments,  was 
randomized. Adequate quantities of DNPs1-BGG and of antibody preparations were incu- 
bated 60 rain at 37°C in a shaking water bath; then the whole mixture was emulsified with an 
equal  volume  of  complete Freund's adjuvant  (Difco  Laboratories,  Detroit,  Mich.).  Each 
animal received 0.2  ml  of emulsion containing 25  /~g  of antigen and  500  #g  of antibody, 
divided between the hind footpads. A booster injection of 100 #g of antigen in saline was given 
on the 12th wk, divided into 6 intradermal sites on the shaved back. 
Determination  of  Active  Responses.--Serum  antidinitrophenyl  (DNP)  IgG1  and  IgG2 
antibody contents were measured by the modified Farr method, using the same reagents and 
the  same  conditions as  those described elsewhere. ~ Actually,  sera from  both  experiments 
2 Abbreviations  used  in  this paper:  BGG,  bovine gamma  globulin; BSA,  bovine serum 
albumin; DH,  delayed hypersensitivity; HGG,  human gamma globulin; PCA,  passive cu- 
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were assayed at random and blindly, irrespective of the treatment a given animal had received. 
All test sera from any one animal were assayed on the same day. 
Delayed hypersensitivity to the carrier was assessed by skin test in four other animals of 
each group  (nine animals in the control group receiving antigen  alone)  on the 5th wk after 
primary immunization, i.e., at the peak of the antihapten antibody response.  10 and 50/~g of 
BGG were injected intradermally 24 h, and Evans blue intravenously 100 min, before sacrifice. 
RESULTS 
Effect of Passive A nticarrier A ntibodies on the IgG2 A ntihapten Response.--As 
shown in Fig. 1, passive IgG2 had a unique effect the 1st wk after immunization, 
the diminution of the antihapten  IgG2  antibody level being highly significant 
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WEEKS  AFTER  PRIMARY  IMMUNIZATION 
FIG.  1.  Groups of six guinea pigs were immunized on day 0 with 25 #g of DNPst-BGG 
either  alone  (X ..... X)  or mixed with 500  /zg of purified  anti-HGG  IgG1  (~  ix)  or 
IgG2 (Am-A)  antibodies. A  booster injection of 100 #g of antigen in saline was given on the 
12th wk (arrow)  and serum was obtained 4 and 10 days later. Active production of anfi-DN-P 
IgG2  antibodies  was assayed by the  Farr  method,  using an anti-IgG2 monospecific rabbit 
serum. Individual determinations were made in duplicate and  the mean computed for each 
group. 
(P  <  0.005,  Student's  t test).  From  the  2nd  wk onward however,  the  IgG2 
response,  although  reduced,  was  the  least  suppressed  of all  groups receiving 
passive antibodies, either antihapten or anficarrier. 
On  the other hand,  passive immunization with anticarrier IgG1  antibodies 
reduces  more  effectively  the  IgG2  antihapten  response,  and  this  to a  degree 
strikingly similar to the one observed after passive antihapten IgG1 antibodies 
and reported elsewhere. 1 The latter point is illustrated in Fig. 2. 
Effect of Passive Anticarrier Antibodies  on the IgG1 Antihapten Response.- 
Unexpected was the absence, from the 2nd wk onward, of a suppressive effect of 
passive anticarrier IgG2 antibodies on this response, as illustrated in Fig. 3. 
Passive anticarrier IgG1  antibodies however are as suppressive as were pas- 
sive antihapten IgG2 antibodies, and this effect is still seen, although not signifi- 268  ANTICARRIER  ANTIBODY  HOMEOSTATIC  FUNCTION 
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WEEKS  AFTER  PRIMARY  IMMUNIZATION 
FIG. 2.  Groups of six guinea pigs were immunized on day 0 with 25 /zg of DNPs]-BGG 
either  alone  (X ..... X)  or mixed with  500  #g  of purified  anti-HOG IgG1  (A--A)  or 
anti-DNP IgGt  (© ....  ©)  antibodies.  A booster injection of 100 #g of antigen in saline 
was given on the 12th wk (arrow).  This graph is a combination of results presented in Fig.  1 
and elsewhere. 1 
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WEEKS  AFTER  PRIMARY  IMMUNIZATION 
FIG.  3.  Groups of six guinea pigs were  immunized on day 0  with 25  #g of DNPs1-BGG 
either  alone  (X .....  X)  or  mixed with  500  #g  of  purified  anti-HGG  IgG1  (A  A)  or 
IgG2  (&---A) antibodies. A  booster injection of 100/Lg of antigen in saline was given on the 
12th wk (arrow), and serum was obtained 4 and 10 days later. Active production of anti-DNP 
IgG1  antibodies  was  assayed by  the  Farr  method,  using an anti-IgG1  monospecific rabbit 
serum. Individual  determinations were  made in duplicate  and  the mean computed for  each 
group. 
cant,  10  days  after  reimmunization.  This  is  the  moment  (Fig.  4)  when  the 
dissociation  between  the  effects  of  passive  IgG1  anticarrier  and  antihapten 
antibodies on the IgG1 antihapten  response is most obvious (P  <  0.0005).  This 
dissociation is one of the bases for the interpretation given in the discussion. PHIL1]?PE  VUAGNAT,  Tttl~Rt~SE  NEVEU,  GUY  ANDR]~ VOISIN  269 
The data, with regard to the effect of passive anticarrier antibodies, are sum- 
marized in Table I. 
Effect  of Passive  IgG1  and  IgG2  Anlibodies  on  Delayed  Hypersensitivity.- 
With the doses of antigen used to skin test the  animals on  the  5th  wk  after pri- 
mary immunization, no clear-cut differences were seen between the experimental 
groups,  whether  they  had  received  passive  IgG1  or  IgG2  anticarrier  or  anti- 
hapten antibodies, although all appeared to be somewhat inhibitory. 
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WEEKS  AFTER  PRIMARY  IMMUNIZATION 
FIG. 4.  Groups of six guinea pigs weze  immunized on day 0  with 25 #g of DNPsz-BGG 
either alone (X. • • X) or mixed with 500 #g of purified anti-HGG IgG1  (/k--~)  or anti- 
DNP  IgG1  (O ....  O)  antibodies. A  booster injection of  100/zg of antigen in saline was 
given on the 12th wk (arrow). This graph is a combination of results presented in Fig. 3 above 
and elsewhere. 1 
TABLE  I 
Action of Passive Anticarrier Antibodies on the Itumoral Antihapten Antibody Response After 
Primary and Secondary Immunization* 
Active anti-DNP response¢ 
Passive anti-HGG 
antibodies used  IgG2  IgG1 
Primary  Secondary  Primary  Secondary 
IgG2  56§  71  94  109 
IgG1  6011  62§  5011  64 
* Primary immunization consisted  of  25  #g  of  antigen emulsified in complete Freund's 
adjuvant with 500  #g of antibody. Antigen alone in saline was used to boost the animals on 
the 12th wk  (secondary immunization). 
:~ The primary response is expressed as its surface area until  the 6th wk,  relative to con- 
trols taken as 100. Results were compared  by Wilcoxon's test. The secondary response is that 
of day 10 after boosting, relative to controls taken as 100. Results were compared by Student's 
t test. 
§ P  <  0.05. 
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DISCUSSION 
The main finding of the present study is the sustained suppressive effect of 
passive IgG1 anticarrier antibodies on the active IgG1 antihapten response, as 
opposed to the delayed enhancing effect of passive IgG1 antihapten antibodies. 
Being available in purified form and of comparable relative avidity, IgG1 and 
IgG2 anti-HGG antibodies were used as anticarrier antibodies, since they are 
directed against a restricted number of determinants of the carrier moiety of the 
DNP-BGG molecule. Theoretically, the ideal system would be to use two differ- 
ent haptens, each one being carrier for the other; but this in the guinea pig does 
not allow delayed hypersensitivity (DH) to be studied. Furthermore, haptens 
do not seem to function as carriers in this species (13). They may do so in the 
mouse (14), and this would not be surprising if haptens induce DH in the mouse 
as they do in the rat (15; T. Neveu, unpublished observations). 
Indeed, the use of complete Freund's adjuvant for sensitization in the studies 
on the carrier effect induces DH to the carrier (13, 16,  17). Carrier and hapten 
determinants are unrelated, separate determinants (14,  17); this conclusion is 
strongly favored by  experiments where  tolerance  to  the  carrier reduces  the 
response to the hapten  (13,  18,  19).  Carrier and hapten determinants must be 
on the same molecule (14, 17, 20), although recent reports challenge this conclu- 
sion (21-24). 
Nonetheless all reports suggest that two separate populations of cells cooper- 
ate, anticarrier thymus-derived T  cells and antihapten non-thymus-derived B 
cells.  How these two populations cooperate is not yet settled. In order to be 
activated, the B cell apparently needs more than one signal: two or more mole- 
cules of antigen cross-linked by anticarrier antibody (25)  or by anticarrier T 
cells,  these being then linked to the B  cell through the antigen (26). In some 
instances,  however, the second signal does not originate in  the antigen under 
study; T  cells might  act on B  cells either directly as in  the  allogeneic effect 
(22, 23) or through the liberation of a mediator induced by their interaction with 
any antigen to which they are sensitized (21, 24). These interpretations must be 
accepted with caution, inasmuch as they are inferred from complex systems in 
which  cross-reactivity between  antigens  might  furthermore  exist.  This,  for 
example, seems to be the case of sheep RBC and horse RBC  (27),  the system 
used by Hartmann  (21).  Finally,  the recent  report  of  Gershon  and  Kondo, 
which suggests that T  cells might produce a  "shut off" substance (28), makes 
any current interpretation even more difficult. 
On the other hand,  a cooperating role of anticarrier antibody appears to be 
invalidated by several experiments  (16,  17,  29).  When given passively,  anti- 
carrier antibodies either have no effect (6, 29) or yield a considerable depression 
of the antihapten response (16, 30). 
This has been our experience in the present study. Yet the IgG1  antihapten 
response was normal  after passive IgG2  anticarrier antibodies  and depressed PHILIPPE  VUAGNAT, THERESE NEVEU, GUY  ANDRE VOISIN  271 
after passive IgG1 anticarrier antibodies. This apparent discrepancy could not 
be accounted for by a difference in the dissociation rate of these two antibody 
classes  from immune complexes. 
The interpretation we favor at  this time is the following: Antibody would 
influence antigen localization through its class and then, at least for IgG1 anti- 
bodies,  influence the immune system according to its specificity, either anti- 
hapten or anticarrier. 
Many observations substantiate these assumptions.  Guinea pig IgG2  anti- 
bodies are cytophilic for macrophages and the strength of the binding is con- 
siderably  increased  when  the  antibody has  reacted  with  the  antigen  (31). 
Similarly, mouse B  cells have a receptor exhibiting a  marked predilection for 
lgG1 antibody, the bond being stabilized when the antibody has reacted with 
the antigen (32, 33). Furthermore, only IgG1 antibodies have been shown to be 
highly thymus dependent in the mouse  (34, 35).  There are many similarities 
between mouse and guinea pig IgG1 antibodies, such as the triggering of passive 
cutaneous anaphylaxis (36, 37); these similarities justify the assumption that 
guinea pig IgG1 antibodies are thymus dependent too. 
Immunization with IgG2-antigen complexes will lead to antigen removal by 
the macrophages. Our observation that anticarrier IgG2  antibodies were less 
suppressive than antihapten IgG2 antibodies may be explained by the fact that 
only part of the few available determinants of our highly hapten-substituted 
carrier protein could combine with the cross-reacting anticarrier antibodies we 
used. 
Immunization with IgGl-antigen complexes,  on the other hand, will promote 
the persistence of the antigen in the immune centers. Antihapten IgG1 antibody 
will mask the haptenic determinants, but at the same time will allow sensitiza- 
tion to the carrier, as suggested by Tada and Okumura (38). This, together with 
the thymic dependency of IgG1 antibodies, would account for the brisk increase 
of antihapten IgG1  antibodies when the antigen is reintroduced. As for anti- 
carrier IgG1 antibodies, they would shut off carrier-specific T cells, this resulting 
in a depressed antihapten antibody response, even after reimmunization, as can 
be noticed for the IgG1 response. 
This interpretation, akin to the "tripartite inactivation model" proposed by 
Sinclair et al. (39), gives a regulatory function to IgG1 antibodies, as suggested 
by  Crowle  and  Hu  (40),  and  further reconciles  the  two  main  alternatives, 
peripheral vs. central, which have been put forward to explain the role of anti- 
body in the regulation of the immune response  (41).  It will doubtless require 
modification as new evidence comes to light, but it would seem for the present to 
be a  convenient summary of significant information. Such  a  scheme at least 
emphasizes the delicate balance and the dynamic intricacies between available 
committed cells, antigenic determinants, and antibodies of the different classes 
at any time during the immune response. 272  ANTICARRIER ANTIBODY HOMEOSTATIC FUNCTION 
SUMMARY 
The effect of passively administered IgG1 and IgG2 anticarrier antibodies on 
the IgG1 and IgG2 antihapten  response has been studied. 
Guinea pigs were immunized with dinitrophenylated bovine gamma globulin 
mixed with purified IgG1 or IgG2 antihuman gamma globulin antibodies,  i.e., 
antibodies directed against a limited range of the carrier determinants. Humoral 
IgG1 and IgG2 anti-DNP  antibody contents were assayed at weekly intervals 
and 4  to  10  days  after  a  booster  injection  of  antigen  in  saline  given  on  the 
12th wk. 
The main finding was the sustained  suppressive  effect of passive  IgG1 anti- 
carrier antibodies on the active IgG1 antihapten response. 
This result is compared with the enhancing effect of passive IgG1 antihapten 
antibodies and is discussed in the light of T  cell-B cell and hapten-carrier rela- 
tionships,  leading  to the proposal of a  regulatory function of the Fc portion of 
the IgG1 anticarrier antibody, combined with the antigen, on the T  cell. 
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available  his computing facilities. We also thank  Mrs.  M.  Hoffmann and  Miss P. Barreau 
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